{"id":"W4281252334","doi":"10.1007/s40265-022-01722-2","title":"New Topical Therapies in Development for Atopic Dermatitis","year":2022,"lang":"en","type":"review","venue":"Drugs","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"","keywords":"Medicine; Atopic dermatitis; Dupilumab; Roflumilast; Intensive care medicine; Apremilast; Dermatology; Disease; Calcineurin; Drug development; Ruxolitinib; Adverse effect; Drug; Pharmacology; Psoriasis; Surgery; Internal medicine; Transplantation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00006043931,0.0001703427,0.0008633647,0.0001196677,0.00005559393,0.000007435002,0.0001150307,0.0001318978,0.001176231],"category_scores_gemma":[0.00004510347,0.0001372559,0.0002172288,0.0001029516,0.00001748116,0.00001896957,0.00004809047,0.0001944794,0.00004412972],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001127116,"about_ca_system_score_gemma":0.0008146476,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006463476,"about_ca_topic_score_gemma":0.000007009535,"domain_scores_codex":[0.999106,0.00005670438,0.0003528371,0.0001916896,0.0001147855,0.000177922],"domain_scores_gemma":[0.9994892,0.0001830464,0.00006731843,0.000172042,0.00000723992,0.00008116326],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000002794019,0.00003871307,0.000242711,0.006959045,0.00009206127,0.00005978467,0.0004372981,5.963637e-9,1.120616e-9,0.0002587398,0.02661026,0.9652986],"study_design_scores_gemma":[0.0004499829,0.00001014561,0.0003929218,0.001742548,0.0001666044,0.00009475754,0.00005249954,2.77322e-7,4.143626e-7,0.0001261947,0.9968348,0.0001288511],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003366043,0.9964659,0.0000290703,0.0003599263,0.0002238336,0.0007300798,0.000006874435,0.00003136358,0.002119343],"genre_scores_gemma":[0.0000239305,0.9939682,0.0008589327,0.0005717536,0.00009654978,0.0004628725,0.0002712922,0.00002099671,0.003725449],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9702246,"threshold_uncertainty_score":0.9997368,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04522105744302725,"score_gpt":0.3383699868870051,"score_spread":0.2931489294439779,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}